SLXP up +0.85% percent Today $SLXP Stock High is at 105.20

Understanding the Invisible Threat of Crawl Space Mold Crawl space mold—it hides in the shadows beneath your home, biding its time until it wreaks havoc on indoor air quality. In the context of New Jersey's environmental quirks, this isn't a trivial concern. With humidity hanging around like an unwanted guest and sneaky water intrusions, those dark nooks under houses...

A Messy Situation Unfolds for Chemours Company You know, stumbling upon a battle scene like this isn't something I enjoy, but here we have Chemours Company (NYSE: CC) embroiled in a securities fraud lawsuit. It's like catching wind of a brawl outside your favorite tavern—can't ignore it, can you? The Lawsuit's Crux and Key Dates to Watch Here's the rundown. The fight...

Pinnacle of Rehab: Encompass Health's Notable Streak You know, in a world where healthcare accolades fly around like confetti, Encompass Health Corp's persistence in being named America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek for the seventh straight year is something to chew on. The fact that a record 78 of its hospitals dotted across 32 states...

Adapting Space or Adapting Business? Here's the thing that keeps popping up in commercial real estate: tenant improvement construction. This isn't just modifying a structure—it's about rethinking how businesses operate within a certain space. The HelloNation article gives you the lowdown straight from Bradley Quakenbush of White Oak Commercial Group. When businesses...

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...

Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Recent Forecast Changes for TELA Bio TELA Bio Inc (NASDAQ: TELA) has recently reported its third-quarter earnings, which presented a mix of results. The company incurred a loss of 19 cents per share, slightly better than analysts had anticipated at 20 cents. However, TELA Bio's quarterly sales totaled $20.7 million, falling short of estimates that predicted $21.8 million....

Morgan Stanley's Bold Move Into Cryptocurrency Morgan Stanley (NASDAQ: MS) has recently made a groundbreaking decision to allow broader client access to digital asset funds. This monumental shift is celebrated by Bitcoin proponent Michael Saylor, who emphasizes the importance of such actions for the cryptocurrency community. Expansion of Crypto Investment Opportunities...

InterDigital's Financial Highlights for Q3 2024 InterDigital, Inc. (NASDAQ: IDCC), a prominent mobile, video, and AI technology research and development company, has announced its financial results for the third quarter. During this period, the company achieved revenues of approximately $129 million, outperforming expectations and marking significant growth compared to...

QVC Unveils the Joy of the Holidays with Mrs. Claus' Holiday House This holiday season, QVC is set to enhance the shopping experience with the introduction of Mrs. Claus' Holiday House. This two-day pop-up event, happening on November 19 and 20 in New York City, promises to offer a delightful mix of unique shopping opportunities and celebrity appearances. With Kathy...

Understanding Genital Psoriasis and Its Impact In recent developments, Arcutis Biotherapeutics has taken a significant step towards addressing the often-overlooked issue of genital psoriasis. By assembling a dedicated Genital Psoriasis Wellness Consortium, this multidisciplinary team focused on enhancing the understanding and treatment of this condition, which...